12:00 AM
 | 
Feb 04, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Fycompa perampanel regulatory update

Eisai said it submitted a regulatory application to South Africa's Medicines Control Council (MCC) for Fycompa perampanel to treat partial-onset seizures,...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >